1. Home
  2. GRI
  3. GRI News

Latest GRI Bio Inc. (GRI) News on June 8, 2025

GRI Bio Presents Positive Pre-Clinical Data Demonstrating GRI-0621 Resolves Inflammation and Fibrosis in Bleomycin-Induced Fibrosis and Reiterates Promising Preliminary Phase 2a Clinical Results
GRI

GlobeNewswire

17 days ago

GRI Bio Presents Positive Pre-Clinical Data Demonstrating GRI-0621 Resolves Inflammation and Fibrosis in Bleomycin-Induced Fibrosis and Reiterates Promising Preliminary Phase 2a Clinical Results

GRI Bio to Participate in the Virtual Investor Closing Bell Series
GRI

GlobeNewswire

18 days ago

GRI Bio to Participate in the Virtual Investor Closing Bell Series

GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase
GRI

GlobeNewswire

23 days ago

GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase

GRI Bio Reports First Quarter 2025 Financial Results and Confirms GRI-0621 Phase 2a IPF Trial on Track for 6-Week Interim Data in Q2 2025 and Topline Data in Q3 2025
GRI

GlobeNewswire

24 days ago

GRI Bio Reports First Quarter 2025 Financial Results and Confirms GRI-0621 Phase 2a IPF Trial on Track for 6-Week Interim Data in Q2 2025 and Topline Data in Q3 2025

GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
GRI

GlobeNewswire

a month ago

GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)

GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
GRI

GlobeNewswire

a month ago

GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)

GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference
GRI

GlobeNewswire

2 months ago

GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference

GRI Bio Announces Closing of $5.0 Million Public Offering
GRI

GlobeNewswire

2 months ago

GRI Bio Announces Closing of $5.0 Million Public Offering

GRI Bio Announces Pricing of $5.0 Million Public Offering
GRI

GlobeNewswire

2 months ago

GRI Bio Announces Pricing of $5.0 Million Public Offering

GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
GRI

GlobeNewswire

2 months ago

GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)

GRI Bio Bolsters Intellectual Property Portfolio with Granting of Two Global Patents for Europe and Japan
GRI

GlobeNewswire

2 months ago

GRI Bio Bolsters Intellectual Property Portfolio with Granting of Two Global Patents for Europe and Japan

GRI Bio Participates in a Virtual Investor CEO Connect Segment
GRI

GlobeNewswire

3 months ago

GRI Bio Participates in a Virtual Investor CEO Connect Segment

GRI Bio Reports Full Year 2024 Financial Results and Reiterates Expected Clinical Data Readouts in 2025 for Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
GRI

GlobeNewswire

3 months ago

GRI Bio Reports Full Year 2024 Financial Results and Reiterates Expected Clinical Data Readouts in 2025 for Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)

GRI Bio Regains Compliance with Nasdaq’s Minimum Bid Price Rule
GRI

GlobeNewswire

3 months ago

GRI Bio Regains Compliance with Nasdaq’s Minimum Bid Price Rule

GRI Bio Announces Reverse Stock Split
GRI

GlobeNewswire

4 months ago

GRI Bio Announces Reverse Stock Split

GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
GRI

GlobeNewswire

4 months ago

GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds
GRI

GlobeNewswire

6 months ago

GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds

GRI Bio to Participate in the Virtual Investor Closing Bell Series
GRI

GlobeNewswire

6 months ago

GRI Bio to Participate in the Virtual Investor Closing Bell Series

GRI Bio Showcases GRI-0621’s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)
GRI

GlobeNewswire

7 months ago

GRI Bio Showcases GRI-0621’s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)

GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis
GRI

GlobeNewswire

7 months ago

GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis

GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024
GRI

GlobeNewswire

7 months ago

GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024

GRI Bio Announces Exercise of Warrants
GRI

GlobeNewswire

8 months ago

GRI Bio Announces Exercise of Warrants

GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621’s Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)
GRI

GlobeNewswire

8 months ago

GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621’s Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)

GRI Bio to Present at the 22nd International Colloquium on Lung and Airway Fibrosis
GRI

GlobeNewswire

8 months ago

GRI Bio to Present at the 22nd International Colloquium on Lung and Airway Fibrosis

GRI Bio Granted Japan Patent for Proprietary Natural Killer T (NKT) Cell Modulators for Prevention and Treatment of Inflammatory Conditions
GRI

GlobeNewswire

8 months ago

GRI Bio Granted Japan Patent for Proprietary Natural Killer T (NKT) Cell Modulators for Prevention and Treatment of Inflammatory Conditions

GRI Bio Receives Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in Australia
GRI

GlobeNewswire

8 months ago

GRI Bio Receives Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in Australia

GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment
GRI

GlobeNewswire

8 months ago

GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment

GRI Bio Participates in Virtual Investor KOL Connect Segment
GRI

GlobeNewswire

9 months ago

GRI Bio Participates in Virtual Investor KOL Connect Segment

GRI Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
GRI

GlobeNewswire

9 months ago

GRI Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GRI Bio to Present at the 2024 European Respiratory Congress
GRI

GlobeNewswire

9 months ago

GRI Bio to Present at the 2024 European Respiratory Congress

GRI Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GRI

GlobeNewswire

10 months ago

GRI Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break Series
GRI

GlobeNewswire

a year ago

GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break Series

GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment
GRI

GlobeNewswire

a year ago

GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment

GRI Bio Regains Compliance with Nasdaq
GRI

GlobeNewswire

a year ago

GRI Bio Regains Compliance with Nasdaq

GRI Bio Announces Publication of Positive Preclinical Data from Lead Program GRI-0621 in the American Journal of Respiratory and Critical Care Medicine
GRI

GlobeNewswire

a year ago

GRI Bio Announces Publication of Positive Preclinical Data from Lead Program GRI-0621 in the American Journal of Respiratory and Critical Care Medicine

GRI Bio to Present at the 8th Annual IPF Summit
GRI

GlobeNewswire

a year ago

GRI Bio to Present at the 8th Annual IPF Summit

GRI Bio Announces Closing of $4.0 Million Public Offering
GRI

GlobeNewswire

a year ago

GRI Bio Announces Closing of $4.0 Million Public Offering

GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators
GRI

GlobeNewswire

a year ago

GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators

GRI Bio Announces Pricing of $4 Million Public Offering
GRI

GlobeNewswire

a year ago

GRI Bio Announces Pricing of $4 Million Public Offering

GRI Bio Announces Reverse Stock Split
GRI

GlobeNewswire

a year ago

GRI Bio Announces Reverse Stock Split

Connect Biopharma Announces New Leadership and Chair of the Board of Directors
GRI

GlobeNewswire

a year ago

Connect Biopharma Announces New Leadership and Chair of the Board of Directors

GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor Pitch Conference
GRI

GlobeNewswire

a year ago

GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor Pitch Conference

GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythematosus (SLE) Programs
GRI

GlobeNewswire

a year ago

GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythematosus (SLE) Programs

GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)
GRI

GlobeNewswire

a year ago

GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)

GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)
GRI

GlobeNewswire

a year ago

GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)

GRI Bio to Present at Alliance Global Partner’s 2024 Healthcare Company Showcase
GRI

GlobeNewswire

a year ago

GRI Bio to Present at Alliance Global Partner’s 2024 Healthcare Company Showcase

GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
GRI

GlobeNewswire

a year ago

GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update

GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity
GRI

GlobeNewswire

a year ago

GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity

GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
GRI

GlobeNewswire

a year ago

GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent
GRI

GlobeNewswire

a year ago

GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent

GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conference
GRI

GlobeNewswire

a year ago

GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conference

GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update
GRI

GlobeNewswire

a year ago

GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update

GRI Bio to Present at the MedInvest Biotech & Pharma Investor Conference
GRI

GlobeNewswire

a year ago

GRI Bio to Present at the MedInvest Biotech & Pharma Investor Conference

GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators
GRI

GlobeNewswire

a year ago

GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators

GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom
GRI

GlobeNewswire

a year ago

GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom

GRI Bio Announces Pricing of $5.5 Million Public Offering
GRI

GlobeNewswire

a year ago

GRI Bio Announces Pricing of $5.5 Million Public Offering

BTC Digital Ltd. Announces Launch of Ethereum (ETH) Staking Services
GRI

PR Newswire

a year ago

BTC Digital Ltd. Announces Launch of Ethereum (ETH) Staking Services

SRM Entertainment Showcases New Products at the 2024 Las Vegas Winter Market Gift Show
GRI

GlobeNewswire

a year ago

SRM Entertainment Showcases New Products at the 2024 Las Vegas Winter Market Gift Show

Windtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
GRI

ACCESSWIRE

a year ago

Windtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company

GRI Bio Announces Reverse Stock Split
GRI

GlobeNewswire

a year ago

GRI Bio Announces Reverse Stock Split

Foresight: Rail Vision's Main Line System Secures EU Railway Standards Approval and Certifications
GRI

GlobeNewswire

a year ago

Foresight: Rail Vision's Main Line System Secures EU Railway Standards Approval and Certifications

Neptune Retains Stifel to Explore Strategic Alternatives for Sprout Organics
GRI

ACCESSWIRE

a year ago

Neptune Retains Stifel to Explore Strategic Alternatives for Sprout Organics

Nuvve Wins $16M Project for Fresno Economic Opportunities Commission's 50-Shuttle Fleet
GRI

PR Newswire

a year ago

Nuvve Wins $16M Project for Fresno Economic Opportunities Commission's 50-Shuttle Fleet

FOXO Technologies Formalizes License Agreement with KR8.ai to Power New Epigenetic Wellness Solutions
GRI

Business Wire

a year ago

FOXO Technologies Formalizes License Agreement with KR8.ai to Power New Epigenetic Wellness Solutions

Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China
GRI

ACCESSWIRE

a year ago

Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China

Laser Photonics Receives Order from Oil City Iron Works for Its CleanTech Laser Cleaning System
GRI

ACCESSWIRE

a year ago

Laser Photonics Receives Order from Oil City Iron Works for Its CleanTech Laser Cleaning System

CENTOGENE Announces Preliminary Full Year 2023 Revenue
GRI

GlobeNewswire

a year ago

CENTOGENE Announces Preliminary Full Year 2023 Revenue

ClearSign Technologies Corporation Announces Successful Start Up of Multi-Burner Heater in California Project
GRI

PR Newswire

a year ago

ClearSign Technologies Corporation Announces Successful Start Up of Multi-Burner Heater in California Project

Sidoti Events, LLC's Virtual January Micro-Cap Conference
GRI

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Horizon Aircraft Completes Business Combination with Pono Capital Three, Inc. to Become a Publicly Traded Company
GRI

GlobeNewswire

a year ago

Horizon Aircraft Completes Business Combination with Pono Capital Three, Inc. to Become a Publicly Traded Company

3 Penny Stocks to Buy to Unlock 2,500% Upside Potential
GRI

InvestorPlace

a year ago

3 Penny Stocks to Buy to Unlock 2,500% Upside Potential

GRI

Business Wire

a year ago

Xos and ElectraMeccanica Announce Proposed Combination to Accelerate Xos’ Leadership Position in Manufacturing Commercial Electric Vehicles for Major U.S. Fleet Customers

SELLAS (SLS) Rises on FDA Fast Track Tag to Leukemia Candidate
GRI

Zacks

a year ago

SELLAS (SLS) Rises on FDA Fast Track Tag to Leukemia Candidate

GRI

ACCESSWIRE

a year ago

Nocera Inc. Announces Senior Leadership Change

Advent Technologies Secures Funding from Danish Energy Technology Development and Demonstration Program for Innovative R&D Project
GRI

Business Wire

a year ago

Advent Technologies Secures Funding from Danish Energy Technology Development and Demonstration Program for Innovative R&D Project

GRI

GlobeNewswire

a year ago

AirNet Announces Receipt of Deficiency Letter from Nasdaq

GRI

GlobeNewswire

a year ago

Aeries Technology to Participate at the 26th Annual ICR Conference

3 EV Stocks to Sell in January Before They Crash and Burn
GRI

InvestorPlace

a year ago

3 EV Stocks to Sell in January Before They Crash and Burn

LED Lighting and EV Charging Solutions Provider Orion to Participate in Virtual Sidoti Microcap Conf. Weds & Thurs, Jan 17-18; Presentation Jan 18th at 10am ET
GRI

GlobeNewswire

a year ago

LED Lighting and EV Charging Solutions Provider Orion to Participate in Virtual Sidoti Microcap Conf. Weds & Thurs, Jan 17-18; Presentation Jan 18th at 10am ET

Harte Hanks Extends Line of Credit with Texas Capital Bank
GRI

ACCESSWIRE

a year ago

Harte Hanks Extends Line of Credit with Texas Capital Bank

Steakholder Foods crafts 3-D printed eel
GRI

Food Dive

a year ago

Steakholder Foods crafts 3-D printed eel

The Ed Mylett Show Joins the Cumulus Podcast Network
GRI

GlobeNewswire

a year ago

The Ed Mylett Show Joins the Cumulus Podcast Network

Are Investors Undervaluing Ardmore Shipping (ASC) Right Now?
GRI

Zacks

a year ago

Are Investors Undervaluing Ardmore Shipping (ASC) Right Now?

Feasibility Report Confirms Regulatory Path in UAE for Steakholder Foods® 3D-Printed, Plant-Based Products
GRI

PR Newswire

a year ago

Feasibility Report Confirms Regulatory Path in UAE for Steakholder Foods® 3D-Printed, Plant-Based Products

Greater Boston-Based Harte Hanks Continues Growth Phase with Addition of Global Advertising Executive Elizabeth Ross to Board of Directors
GRI

ACCESSWIRE

a year ago

Greater Boston-Based Harte Hanks Continues Growth Phase with Addition of Global Advertising Executive Elizabeth Ross to Board of Directors

Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device
GRI

PR Newswire

a year ago

Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device

PINTEC Announces Appointment of New Chief Financial Officer
GRI

PR Newswire

a year ago

PINTEC Announces Appointment of New Chief Financial Officer

Estimating The Intrinsic Value Of AirNet Technology Inc. (NASDAQ:ANTE)
GRI

Simply Wall St.

a year ago

Estimating The Intrinsic Value Of AirNet Technology Inc. (NASDAQ:ANTE)

How Did Aeries Technology, Inc's (NASDAQ:AERT) 13% ROE Fare Against The Industry?
GRI

Simply Wall St.

a year ago

How Did Aeries Technology, Inc's (NASDAQ:AERT) 13% ROE Fare Against The Industry?

BiggerPockets Podcast Network Moves to Cumulus
GRI

GlobeNewswire

a year ago

BiggerPockets Podcast Network Moves to Cumulus

Former Director of Security of the Israeli Defense Establishment Nir Ben Moshe Joining ParaZero
GRI

GlobeNewswire

a year ago

Former Director of Security of the Israeli Defense Establishment Nir Ben Moshe Joining ParaZero

Clene Provides Update on ALS Clinical Development Meeting With FDA
GRI

GlobeNewswire

a year ago

Clene Provides Update on ALS Clinical Development Meeting With FDA

Medigus: ParaZero Successfully Completed its Drone Safety Project with a Fortune 500 Leading Automotive Manufacturer
GRI

GlobeNewswire

a year ago

Medigus: ParaZero Successfully Completed its Drone Safety Project with a Fortune 500 Leading Automotive Manufacturer

How Clene CNM-Au8(R) Takes Advantage of Gold Nanocrystals to Target Neurodegenerative Disorders
GRI

NewMediaWire

a year ago

How Clene CNM-Au8(R) Takes Advantage of Gold Nanocrystals to Target Neurodegenerative Disorders

CENTOGENE Announces Voting Results of Extraordinary General Meeting
GRI

GlobeNewswire

a year ago

CENTOGENE Announces Voting Results of Extraordinary General Meeting

HUB Announces Reverse Share Split
GRI

GlobeNewswire

a year ago

HUB Announces Reverse Share Split

GRI

News Direct

2 years ago

GRI Bio begins patent enrollment for Phase 2a study of GRI-0621 for IPF treatment

Cocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza A
GRI

GlobeNewswire

2 years ago

Cocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza A

GRI Bio Commences Patient Enrollment in Phase 2a Biomarker Study Evaluating Lead Program GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)
GRI

GlobeNewswire

2 years ago

GRI Bio Commences Patient Enrollment in Phase 2a Biomarker Study Evaluating Lead Program GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)

Neptune Wellness Announces Receipt of Nasdaq Delisting Notice and Intention to Appeal
GRI

ACCESSWIRE

2 years ago

Neptune Wellness Announces Receipt of Nasdaq Delisting Notice and Intention to Appeal

Share on Social Networks: